Tag Archives: sodium-glucose co-transport 2 (SGLT2) inhibitors
April 2021 Br J Cardiol 2021;28:56–61 doi:10.5837/bjc.2021.018
Eligibility for dapagliflozin in unselected patients hospitalised with decompensated heart failure
Hibba Kurdi, Parin Shah, Simon Barker, Daniel Harris, Benjamin Dicken, Carey Edwards, Geraint Jenkins
(more…)
For healthcare professionals only
